Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Katherine Bach Kalin

Director at SELLAS Life Sciences Group, Inc. (SLS)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+164.1%
vs. S&P 500+159.9%
Beat the market100%
Paper profit on buys+$638K
Total bought / sold$101K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Nov 21SEC SLSSELLAS Life Sciences Group, Inc. Buy 63,400104,400 held (+155%) $1.59 $101K +632.7%
  • Buy

    Director Katherine Bach Kalin bought $101K of SLS at $1.59 — first open-market purchase in our records; raises the stake by 155%.